Hybrid AF Therapy | EPi-Sense ST System
The Latest Innovation in Deflection and Control for Epicardial Atrial Fibrillation Ablation for the Treatment of Advanced Afib Patients
Top Workplaces 2023
Ready to work at a Top Workplace?
First Patient Treated in LeAAPS Clinical Trial
Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
Find a Specialist
Search for a qualified Hybrid AF Therapy treatment team
First Patient Treated in HEAL-IST™ Trial
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator Synergy Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia
0
Patients Served with Ablation Worldwide
0
AtriClip Devices Sold Worldwide
U.S. NEWS
AtriCure Reports Second Quarter 2023 Financial Results
REDUCING GLOBAL AFIB
What is Afib, and how does it affect heart performance?
CAREERS
Interested in joining our mission to reduce the global Afib epidemic?
THERAPY INNOVATION
Post-Operative Pain Management: Opening the Door to Some Cool Options
PM-US-0301J-0525-G
© 2023 Atricure, Inc. All Rights Reserved.
Explore the LeAAPS™ trial, the biggest randomized cardiac surgery trial. Its unique setup will assess LAA exclusion safety and efficacy in preventing strokes for high-risk patients without AF history. Learn more about LeAAPS at https://bit.ly/443NaVt
Explore the LeAAPS™ trial, the biggest randomized cardiac surgery trial. Its unique setup will assess LAA exclusion safety and efficacy in preventing strokes for high-risk patients without AF history. Learn more about LeAAPS at https://bit.ly/443NaVt
EPi-Sense ST™ provides consistent tissue contact and energy delivery, resulting in complete lesions. Learn more about the EPi-Sense ST and view ISI at http://bit.ly/EpiSenseST #CarioTwitter PM-US-2903A-0725-G
EPi-Sense ST™ provides consistent tissue contact and energy delivery, resulting in complete lesions. Learn more about the EPi-Sense ST and view ISI at http://bit.ly/EpiSenseST #CarioTwitter PM-US-2903A-0725-G
36 years ago, Dr. James Cox performed the first Cox-Maze procedure. Hear from Dr. Cox on how this first-of-its-kind procedure came to be. Today, Cox Maze IV yields the highest efficacy for Afib treatment. https://bit.ly/3PopLtX
36 years ago, Dr. James Cox performed the first Cox-Maze procedure. Hear from Dr. Cox on how this first-of-its-kind procedure came to be. Today, Cox Maze IV yields the highest efficacy for Afib treatment. https://bit.ly/3PopLtX
Better patient outcomes and a reduction in hospital resources? It’s possible with Hybrid AF™ Therapy. https://bit.ly/HybridAFTherapy #cardiac #hybridaf
Better patient outcomes and a reduction in hospital resources? It’s possible with Hybrid AF™ Therapy. https://bit.ly/HybridAFTherapy #cardiac #hybridaf
social media channels to keep updated on the latest at AtriCure.